Insmed (INSM)
Insmed Statistics
Share Statistics
Insmed has 181M shares outstanding. The number of shares has increased by 20.48% in one year.
| Shares Outstanding | 181M |
| Shares Change (YoY) | 20.48% |
| Shares Change (QoQ) | 4.1% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 176.82M |
| Failed to Deliver (FTD) Shares | 13 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 15.09M, so 8.43% of the outstanding shares have been sold short.
| Short Interest | 15.09M |
| Short % of Shares Out | 8.43% |
| Short % of Float | 8.64% |
| Short Ratio (days to cover) | 7.71 |
Valuation Ratios
The PE ratio is -12.39 and the forward PE ratio is -18.39. Insmed's PEG ratio is -2.88.
| PE Ratio | -12.39 |
| Forward PE | -18.39 |
| PS Ratio | 31.14 |
| Forward PS | 3.8 |
| PB Ratio | 39.69 |
| P/FCF Ratio | -16.05 |
| PEG Ratio | -2.88 |
Enterprise Valuation
Insmed has an Enterprise Value (EV) of 5.07B.
| EV / Earnings | -5.55 |
| EV / Sales | 13.95 |
| EV / EBITDA | -6.2 |
| EV / EBIT | -5.78 |
| EV / FCF | -7.19 |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.45 |
| Quick Ratio | 5.12 |
| Debt / Equity | 0.16 |
| Total Debt / Capitalization | 13.75 |
| Cash Flow / Debt | -15.03 |
| Interest Coverage | -10.94 |
Financial Efficiency
Return on equity (ROE) is -3.2% and return on capital (ROIC) is -266.52%.
| Return on Equity (ROE) | -3.2% |
| Return on Assets (ROA) | -0.45% |
| Return on Capital (ROIC) | -266.52% |
| Revenue Per Employee | $286,158.14 |
| Profits Per Employee | $-718,939.42 |
| Employee Count | 1,271 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | 3.71M |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 202.35% in the last 52 weeks. The beta is 1.28, so Insmed's price volatility has been higher than the market average.
| Beta | 1.28 |
| 52-Week Price Change | 202.35% |
| 50-Day Moving Average | 76.74 |
| 200-Day Moving Average | 72.87 |
| Relative Strength Index (RSI) | 54.86 |
| Average Volume (20 Days) | 1.79M |
Income Statement
In the last 12 months, Insmed had revenue of 363.71M and earned -913.77M in profits. Earnings per share was -5.57.
| Revenue | 363.71M |
| Gross Profit | 277.96M |
| Operating Income | -878.25M |
| Net Income | -913.77M |
| EBITDA | -818.79M |
| EBIT | -878.25M |
| Earnings Per Share (EPS) | -5.57 |
Balance Sheet
The company has 555.03M in cash and 45.49M in debt, giving a net cash position of 509.54M.
| Cash & Cash Equivalents | 555.03M |
| Total Debt | 45.49M |
| Net Cash | 509.54M |
| Retained Earnings | -4.36B |
| Total Assets | 2.03B |
| Working Capital | 1.32B |
Cash Flow
In the last 12 months, operating cash flow was -683.88M and capital expenditures -21.92M, giving a free cash flow of -705.8M.
| Operating Cash Flow | -683.88M |
| Capital Expenditures | -21.92M |
| Free Cash Flow | -705.8M |
| FCF Per Share | -4.3 |
Margins
Gross margin is 76.43%, with operating and profit margins of -241.47% and -251.24%.
| Gross Margin | 76.43% |
| Operating Margin | -241.47% |
| Pretax Margin | -250.22% |
| Profit Margin | -251.24% |
| EBITDA Margin | -225.12% |
| EBIT Margin | -241.47% |
| FCF Margin | -194.06% |
Dividends & Yields
INSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6.97% |
| FCF Yield | -4.88% |
Analyst Forecast
The average price target for INSM is $97, which is 21.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $97 |
| Price Target Difference | 21.4% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
Stock Splits
The last stock split was on Mar 3, 2011. It was a backward split with a ratio of 1:10.
| Last Split Date | Mar 3, 2011 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 1.47 |
| Piotroski F-Score | 3 |